ARAnnemarieke Rutten

Annemarieke Rutten

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Annemarieke Rutten has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Biphasic contrast medium injection in cardiac CT: moderate versus high concentration contrast material at identical iodine flux and iodine dose

    by Annemarieke Rutten, Matthijs F. L. Meijs, Alexander M. de Vos, Peter R. Seidensticker, Mathias Prokop

    Objective To prospectively investigate the influence of contrast material concentration on enhancement in cardiac CT by using a biphasic single-injection protocol. Methods Sixty-four-row multidetector cardiac CT angiography was performed in 159 patients randomised to a moderate or high contrast medium concentration. Contrast material injection included a first phase for enhancement of the coronary arteries and a second phase, at half the iodine flux, targeted at enhancement of the right ventricle. Contrast medium injection was followed by a saline flush. For both concentrations, injection duration (and thus total iodine dose) was adapted to the duration of the CT data acquisition and iodine flux was adjusted to patient weight. Attenuation was measured at various levels in the heart and vessels and the two concentrations compared, overall and per weight group. Results Enhancement of the aorta and left ventricle was significantly greater with the moderate than with the high concentration contrast medium. This remained true for the two higher weight groups. No difference was found in the lowest weight group or in the right ventricle and pulmonary outflow tract. Conclusion With a biphasic injection protocol, enhancement of the aorta and left ventricle was weaker with the higher concentration of contrast material.


  • Variability of Coronary Calcium Scores Throughout the Cardiac Cycle

    by Annemarieke Rutten, Sébastien P. J. Krul, Matthijs F. L. Meijs, Alexander M. de Vos, Maarten-Jan M. Cramer, Mathias Prokop

    To study how much the calcium scores at various phases throughout the cardiac cycle deviate from the score in the most motionless phase during retrospectively electrocardiogram (ECG)-gated multidetector row computed tomography (MDCT) of the heart and to evaluate how to optimize ECG-based tube current modulation so that errors in calcium scoring can be minimized while dose savings can be maximized. In 73 subjects with known or suspected coronary artery disease we performed retrospectively ECG-gated 64-detector row computed tomography for calcium scoring. Four subjects were excluded after scanning because of breathing artifacts or lack of coronary calcification. The scans of 69 subjects (46 men, mean age 62 +/- 6 years) were used for further analysis. Heart rate during the scan was recorded. In each patient, calcium scoring [Agatston score (AS), mass score (MS), and volume score, (VS)] was performed on 10 data sets reconstructed at 10%-intervals throughout the cardiac cycle. The most motionless phase was subjectively determined and used as the reference phase. For the score in each phase, deviation from the score in the reference phase was determined. An ECG-simulator was used to determine the amount of dose saving while scanning with dose modulation and applying diagnostic dose during 1 or several phases. Mean heart rate was 63 (+/-13) beats per minute (bpm). In 51% of patients the reference phase was the 70% phase. Using the calcium score in the 70% phase (mid-diastole) instead of the reference at heart rates below 70 bpm would have induced a median score deviation of 0% [interquartile range: 0%-6% (AS, MS, and VS)] and using the calcium score in the 40% phase (end-systole) at heart rates > or =70 bpm would also have induced a median score deviation of 0% [interquartile range: 0%-7% (AS), 0%-5% (MS), and 0%-3% (VS)]. Errors in calcium scores of more than 10% occur in around 10% of subjects for all 3 scoring algorithms. Dose savings increased with lower heart rates and shorter application of diagnostic dose. The optimum phases for dose modulation are 70% (mid-diastole) at heart rates below 70 bpm and 40% (end-systole) at heart rates above 70 bpm. Under these conditions dose saving is maximum and a median error of 0% is found for the various calcium scoring techniques with score errors of more than 10% in around 10% of subjects.


  • Coronary Calcification: Effect of Small Variation of Scan Starting Position on Agatston, Volume, and Mass Scores

    by Annemarieke Rutten, Ivana Isgum, Mathias Prokop

    To retrospectively evaluate the effect of a small variation of scan starting position on coronary artery calcium scores based on nonoverlapping 3-mm multidetector computed tomographic (CT) data sets. Informed consent and institutional review board approval were obtained. A retrospective study was performed by using prospective unenhanced electrocardiographically triggered cardiac multidetector CT scans in 228 women (mean age, 67 years +/- 5 [standard deviation]). From the original 1.5-mm data set, two sets of adjacent images with a section thickness of 3 mm and a variation in starting point of 1.5 mm were obtained. Calcium scoring was performed to acquire Agatston, volume, and mass scores. Subjects were assigned to one of five risk categories (I-V) according to the Agatston score of each 3-mm data set and the average score. Kappa value was calculated to assess agreement in risk category assignment. Differences and relative differences between scores obtained for both 3-mm data sets were calculated overall and according to risk category. The effect of scoring algorithm on the relative differences between scores was analyzed with the Wilcoxon signed rank test. Categories I-V contained 102, 35, 48, 31, and 12 subjects, respectively. For all scoring algorithms, median relative differences decreased from more than 130% in category II to less than 10% in category V. In the three highest categories, relative differences were significantly smaller for volume and mass scores than for Agatston scores (P < .05). Twenty-one subjects were assigned to different risk categories between the two data sets (kappa = 0.87). Eleven patients were assigned a nonzero score in one and a zero score in the other data set. A small variation in scan starting position can substantially influence calcium measurements and poses an inherent limit to calcium scoring with contiguous 3-mm sections. Mass and volume scores are slightly less affected than are Agatston scores.


  • Contrast Agents in X-Ray Computed Tomography and Its Applications in Oncology

    by Annemarieke Rutten, Mathias Prokop

    Intravascular iodinated contrast agents are required for a large proportion of computed tomography (CT) studies. Contrast media are indispensable to more clearly differentiate anatomic structures and to detect and characterize abnormalities. Depending on the indication up to 200 ml of these agents are injected during CT. Despite these large amounts adverse effects are rare and have further decreased with the introduction of non-ionic substances. However, it took 10 to 20 years until these non-ionic agents replaced the older ionic agents in clinical practice. In recent years no new substance has been brought to the market. The introduction of rapid scanning using multislice CT technology, however, has led to the development of more sophisticated contrast injection techniques. Current research focuses on optimizing contrast application techniques and on further evaluating the safety profiles of the various substances. The amount of contrast enhancement obtained in individual patients for instance depends on the contrast agent characteristics, such as iodine concentration, and the parameters of the contrast injection protocol, such as iodine flux and iodine dose. Meanwhile, contrast agent characteristics such as osmolality and viscosity play a role in the safety profile of an agent. This paper provides a current overview of CT contrast media, CT contrast dynamics, and CT contrast applications with a special focus on oncological imaging.